Mereo BioPharma Group PLC (MREO)
3.71
-0.11
(-2.88%)
USD |
NASDAQ |
Nov 15, 09:40
Mereo BioPharma Group Cash and Equivalents (Quarterly)
Cash and Equivalents (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Equivalents (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| June 30, 2023 | -- |
| December 31, 2022 | -- |
| June 30, 2022 | -- |
| June 30, 2022 | -- |
| December 31, 2021 | -- |
| June 30, 2021 | -- |
| June 30, 2021 | -- |
| December 31, 2020 | -- |
| June 30, 2020 | -- |
| June 30, 2020 | -- |
| December 31, 2019 | -- |
| Date | Value |
|---|---|
| June 30, 2019 | -- |
| June 30, 2019 | -- |
| December 31, 2018 | -- |
| June 30, 2018 | -- |
| June 30, 2018 | -- |
| December 31, 2017 | -- |
| June 30, 2017 | -- |
| June 30, 2017 | -- |
| December 31, 2016 | -- |
| June 30, 2016 | -- |
| June 30, 2016 | -- |
| December 31, 2015 | -- |
Cash and Equivalents Definition
Cash and equivalents is cash or cash equivalents that a company possesses at any given time. Examples of cash equivalents are: money market accounts, treasury bills, and short term government bonds. Cash and cash equivalents are a business' most liquid assets. Cash on hand results from a positive cash flow statement.